ACURX PHARMACEUTICALS, Inc. Announces Closing of INITIAL Public Offering OF common stock AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

June 29, 2021
8:01 pm

ACURX PHARMACEUTICALS, Inc. Announces Closing of INITIAL Public Offering OF common stock AND FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES

STATEN ISLAND, N.Y., June 29, 2021 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) (the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

Crypto News Today: Pepeto Announces $7.43M Raised As Bull Run Approaching And Traders Search For The Next Dogecoin

March 2, 2026

Zero Fees, 5,000 USDT Prize Pool, and a New Era for Crypto in Bolivia

March 2, 2026

World’s money launderers are shifting to crypto, report warns – POLITICO

March 2, 2026

Warren Buffett Stocks: Here’s What Berkshire Hathaway Is Buying Or Selling

March 2, 2026

Crypto Losses Hit 11-Month Low in February, Says PeckShield

March 2, 2026

How to turn $10 a day into long-term wealth on the ASX

March 2, 2026

Crypto Investors Cautious as Iran Conflict Continues

March 2, 2026

If I Could Only Buy 1 ETF In March, This Would Be It

March 2, 2026